Klima Stefanie, Hurrell Tracey, Goolam Mubeen, Gouws Chrisna, Engelbrecht Anna-Mart, Kaur Mandeep, van den Bout Iman
Centre for Neuroendocrinology and Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa.
Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa; Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, South Africa.
Transl Oncol. 2025 Jun;56:102391. doi: 10.1016/j.tranon.2025.102391. Epub 2025 Apr 13.
The advent of in vitro models such as induced pluripotent stem cells (iPSC) and patient derived (disease) organoids is supporting the development of population and patient specific model systems reflecting human physiology and disease. However, there remains a significant underrepresentation of non-European, especially African model systems. The development of such models should be enthusiastically embraced by Sub-Saharan African countries (SSAC) and middle-income countries (LIMC) to direct their own research focused on the improvement of health of their own populations at a sustainable cost within their respective funding environments. Great care needs to be taken to develop national frameworks to direct, sustainably fund and support such efforts in a way that maximises the output of such models for the investment required. Here, we highlight how advanced culture models can play a role in vitalising local healthcare research by focusing on locally relevant health care questions using appropriate cell culture models. We also provide a potential national platform example that could maximise such output at the lowest cost. This framework presents an opportunity for SSAC and LMIC to base their healthcare research on locally relevant models to ensure that developed health care initiatives and interventions are best suited for the populations they serve and thus represent a reset in global health care research at large.
诱导多能干细胞(iPSC)和患者来源的(疾病)类器官等体外模型的出现,正在推动反映人类生理和疾病的群体特异性和患者特异性模型系统的发展。然而,非欧洲尤其是非洲模型系统的代表性仍然严重不足。撒哈拉以南非洲国家(SSAC)和中等收入国家(LIMC)应积极推动此类模型的开发,以便在各自的资金环境下,以可持续的成本指导本国针对改善本国人口健康状况的研究。在制定国家框架以指导、可持续资助和支持此类工作时,需要格外谨慎,以实现此类模型在所需投资下的最大产出。在此,我们强调先进的培养模型如何通过使用适当的细胞培养模型关注本地相关的医疗问题,从而在振兴本地医疗研究中发挥作用。我们还提供了一个潜在的国家平台示例,该平台可以以最低的成本实现此类最大产出。该框架为SSAC和LIMC提供了一个机会,使他们的医疗研究基于本地相关模型,以确保所开发的医疗保健举措和干预措施最适合他们所服务的人群,从而在总体上重塑全球医疗研究。